Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Receivables (2016 - 2023)

Historic Receivables for Palisade Bio (PALI) over the last 13 years, with Q1 2023 value amounting to $300000.0.

  • Palisade Bio's Receivables changed N/A to $300000.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $300000.0, marking a year-over-year change of. This contributed to the annual value of $141250.0 for FY2022, which is N/A changed from last year.
  • Latest data reveals that Palisade Bio reported Receivables of $300000.0 as of Q1 2023.
  • Over the past 5 years, Palisade Bio's Receivables peaked at $466782.0 during Q1 2019, and registered a low of $21064.0 during Q4 2019.
  • Its 5-year average for Receivables is $226845.4, with a median of $246976.0 in 2020.
  • In the last 5 years, Palisade Bio's Receivables plummeted by 9411.61% in 2019 and then skyrocketed by 126726.17% in 2020.
  • Palisade Bio's Receivables (Quarter) stood at $21064.0 in 2019, then soared by 1267.26% to $288000.0 in 2020, then tumbled by 79.51% to $59000.0 in 2021, then soared by 139.41% to $141250.0 in 2022, then soared by 112.39% to $300000.0 in 2023.
  • Its Receivables was $300000.0 in Q1 2023, compared to $141250.0 in Q4 2022 and $59000.0 in Q2 2021.